Stay updated on PM01183 Escalating Doses with Doxorubicin Clinical Trial
Sign up to get notified when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.

Latest updates to the PM01183 Escalating Doses with Doxorubicin Clinical Trial page
- CheckyesterdayChange DetectedThe Record History now includes a new revision entry v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry labeled v3.3.3 was added, and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Record History page; this is a minor site update with no changes to study details.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the banner notice about a lapse in government funding and operating status guidance on the page.SummaryDifference0.7%

- Check72 days agoChange DetectedThe new screenshot shows the same version history entries with only minor formatting adjustments; no core study data or status information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check101 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference12%

Stay in the know with updates to PM01183 Escalating Doses with Doxorubicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.